Microstructure of the non-rapid eye movement sleep electroencephalogram in patients with newly diagnosed Parkinson's disease: effects of dopaminergic treatment.

We investigated non-rapid eye movement (non-REM) sleep in patients with newly diagnosed Parkinson's disease (PD) who had never previously received dopaminergic medication. There were no significant differences in the conventional sleep parameters between de novo patients with PD and a healthy control group, but the length of stage 1 sleep and the number of awakenings increased significantly upon administration of dopaminergic drugs. Analyzing the quantitative electroencephalogram (EEG), we observed a significant reduction in the low-delta frequency range and a nonsignificant increase in the sigma frequency range in de novo patients with PD. The dopaminergic medication also nonsignificantly reduced the low-delta and sigma frequencies, the latter to the level of the controls. Possible mechanisms that may account for the observed differences are discussed. It is suggested that Parkinson's disease as well as the application of dopaminergic drugs exerts a desynchronizing effect on the sleep EEG that is reflected in a disruption of sleep continuity.     

GraVes眼病炎性活动期与静止期血清sICAM-1水平的研究

目的:研究可溶性细胞间粘附因子-1(sICAM-1)在Graves眼病(GO)炎性活动期与静止期的水平差异及其与各项甲状腺功能指标的关系。方法:将GO炎性活动期与静止期患者,Graves病(GD)无眼病患者及正常对照,分为A、B、C、D四组,抽取空腹静脉全血,测血清sICAM-1,各组间进行比较。并分析各组sICAM-1与FT3、FT4、TG、TM的相关关系。结果:①A、B、C组患者血清sICAM-1均明显高于正常对照组(P<0.05)。A组患者sICAM-1水平最高,与B组及C组患者相比有统计学差异(P<0.01);②前三组各组内sICAM-1与FT3、FT4成直线相关关系,与TG、TM成直线相关关系;③GO炎性活动期患者sICAM-1与GO评分成正相关。结论:血清sICAM-1水平可作为反映GO活动性评判的免疫指标,长期监测sICAM-1可预示GD进展为临床活动性眼病的可能性。     

Testosterone not associated with violent dreams or REM sleep behavior disorder in men with Parkinson's.

We examined the relationship between testosterone levels, violent dreams, and REM sleep behavior disorder (RBD) in 31 men with Parkinson's disease (PD): 12 with clinical RBD and 19 without. All PD patients with clinical RBD experienced violent dreams, but none of the 19 non-RBD patients reported violent dreams. While dream content appears to be more aggressive in PD patients with clinical RBD, the presence of violent dreams or clinical RBD is not associated with testosterone levels in men with PD.     

老年病人睡眠状况及护理干预研究进展

综述了老年人睡眠质量及其影响因素、睡眠障碍的危害、老年病人睡眠的护理干预。建议进行前瞻性干预试验,为改善老年人的睡眠质量提供依据。     

原发性强直性脊柱炎的早期临床特点

目的 探讨原发性强直性脊柱炎（ＡＳ）的早期临床特点。方法 １２０例ＡＳ的早期临床特点。结果 该组病人的发病出现１６－２０岁和３０－３５岁两上发作年龄高山峰，初发年龄较低；外周关节受累的频率较脊柱高；下肢大和骶骼关节常易受累，其中髋关节，膝关节、踝关节和胸锁关节受累的频率分别为７９％，８５％，５７％和６３％，小关节受累少见，虹膜为和主动脉关闭不全的发生率１２．５％和４．５％，未发现有前更炎和类风湿结     

Delayed sleep phase syndrome: A placebo-controlled cross-over study on the effects of melatonin administered five hours before the individual dim light melatonin onset

In a double-blind placebo-controlled cross-over study, 30 patients with Delayed Sleep Phase Syndrome (DSPS) were included, of whom 25 finished the study. Melatonin 5 mg was administered during two weeks in a double-blind setting and two weeks in an open setting successively or interrupted by two weeks of placebo. The study's impact was assessed by measurements of the 24-h curves of endogenous melatonin production and rectal temperature (n=14), polysomnography (n=22), actigraphy (n=13), sleep log (n=22), and subjective sleep quality (n=25). Mean dim light melatonin onset (DLMO) (±SD), before treatment, occurred at 23.17 hours (±138 min). Melatonin was administered five hours before the individual DLMO. After treatment, the onset of the nocturnal melatonin profile was significantly advanced by approximately 1.5 hour. Body temperature trough did not advance significantly. During melatonin use, actigraphy showed a significant advance of sleep onset and polysomnography, a significant decreased sleep latency. Sleep architecture was not influenced. During melatonin treatment patients felt significantly more refreshed in the morning. These results show that analysis of DLMO of patients suffering from DSPS is important both for diagnosis and therapy. These results are discussed in terms of the biochemistry of the pineal.     

Obstructive sleep apnoea: The role of the oral and maxillofacial surgeon

Obstructive sleep apnoea is a relatively common sleep disorder that is popularly associated with snoring and excessive daytime sleepiness. It is a disorder with serious implications that has only in the last two decades received the attention of clinical specialists. The aim of this article is to review the role of the dental profession in the recognition and management of this disorder.     

������ȫ��˯�߰�������������������ٹ��ܵ�Ӱ��

目的通过建立完全性睡眠剥夺的幼鼠模型,探讨短期完全性睡眠剥夺对幼鼠体温调节及生长的影响。方法2005-01-03将上海交通大学附属新华医院儿科研究所12只出生后3周刚断奶的雄性幼鼠,随机分为试验组和对照组。采用小站台水环境的方法对幼鼠进行48h的睡眠剥夺。睡眠剥夺前、24h及48h后,分别进行体温、体重及进食量的监测,并计算日能耗,睡眠剥夺结束后处死幼鼠并对重要脏器进行称量。结果实验结果表明48h睡眠剥夺后,两组幼鼠体温均出现随时间变化特点,在睡眠剥夺24h后增高,48h后出现体温下降;睡眠剥夺后试验组幼鼠体重明显低于对照组,而试验组的进食量在48h后明显多于对照组;在日能量消耗的比较中,试验组在24h睡眠剥夺后的能耗明显高于对照组;睡眠剥夺48h后各器官重量仅双肺重量与体重的比值在两组间存在差异。结论幼鼠完全性睡眠剥夺的早期即出现体温显著下降,较早显现体温调节中枢的失衡,并且体格发育受到显著影响。     

Absence of effects of prolonged simvastatin therapy on nocturnal sleep in a large randomized placebo-controlled study

1It has been suggested that lipophilic HMG CoA reductase inhibitors, like lovastatin and simvastatin, may cause sleep disturbance. 2Six hundred and twenty-one patients at increased risk of coronary heart disease were randomized in a single centre to receive 40 mg daily simvastatin, 20 mg daily simvastatin or matching placebo. To assess the effects of prolonged use of simvastatin on nocturnal sleep quality and duration, a sleep questionnaire was administered to 567 patients (95% of 595 survivors) at an average of 88 weeks (range: 44–129 weeks) after randomization. 3The main outcome measures were sleep-related problems and use of sleep-enhancing medications reported during routine study follow-up visits, and responses to the sleep questionnaire about changes in sleep duration and about various sleep events during the preceding month. 4No differences were observed between the treatment groups in the frequency of sleep-related problems reported, in the proportion of follow-up visits at which such problems were reported, or in the use of sleep-enhancing medications. The numbers who stopped study treatment were similar in the different treatment groups, and no patient stopped principally because of insomnia. In response to the sleep questionnaire, there were no significant differences between the treatment groups in reports of various sleep events during the preceding month, except that slightly fewer patients allocated simvastatin reported waking often. No differences in sleep duration were observed. 5This placebo-controlled trial does not indicate any adverse effects of prolonged treatment with simvastatin on systematically sought measures of sleep disturbance.     

Effect of forward rapidly rotating shift work on circadian rhythms of arterial pressure, heart rate and oral temperature in air traffic controllers

Twenty-four-hour records of arterial pressure (AP), heart rate(HR), oral temperature (OT) and physical and mental performancewere obtained in air traffic controllers during morning (n=16),afternoon (n=17) and night (n=19) shifts. Data were analyzedby the cosinor method. The results obtained during the morningshift were as follows (mesor/amplitude/;acrophase): systolicAP (mm Hg)—113.6/10.0/16:03 h; diastolic AP—71.1/8.2—15:19h; mean AP—85.6/8.8/15:41 h; HR (beats/min)—77.5/8.9/16:00h; OT (dg C)—36.71/0.21/15:49 h; right-hand grip strength(kg)—49.8/2.0/17:43 h; left-hand grip strength—46.1/2.0/16.08h; mental performance (calculations/min)—14.9/1.1/16:39h. During the night shift either no change of the circadianacrophases (HR, right-hand grip strength) or acrophase delaysranging from about 2 h (systolic AP, OT, mental performance)up to 3 h (diastolic and mean AP, left-hand grip strength) wereobserved. Our data suggest that the shift system studied doesnot significantly alter the circadian rhythms, and does notinduce a desynchronization, particularly as concerns arterialpressure and oral temperature.